Daniil Gataulin
Stock Analyst at Chardan Capital
(1.99)
# 2,858
Out of 4,784 analysts
75
Total ratings
30.88%
Success rate
-2.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLSD Clearside Biomedical | Maintains: Buy | $6 | $0.95 | +531.58% | 4 | Mar 28, 2025 | |
| UBX Unity Biotechnology | Maintains: Buy | $6 → $4 | $1.14 | +250.88% | 3 | Mar 25, 2025 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $11 → $8 | $0.42 | +1,824.46% | 6 | Mar 21, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $7.83 | +564.11% | 10 | Mar 20, 2025 | |
| CRVO CervoMed | Maintains: Buy | $14 | $9.48 | +47.68% | 5 | Mar 18, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $28 | $19.18 | +45.99% | 5 | Mar 13, 2025 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $33 | $5.83 | +466.04% | 10 | Mar 6, 2025 | |
| OCGN Ocugen | Maintains: Buy | $6 → $7 | $0.80 | +775.55% | 10 | Mar 6, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $36 | $7.33 | +391.13% | 3 | Feb 24, 2025 | |
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 | $1.32 | +127.27% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 | $8.20 | +680.49% | 3 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $40 | $4.61 | +767.68% | 5 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $2.78 | +7,826.50% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.91 | - | 2 | Jul 25, 2023 |
Clearside Biomedical
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $0.95
Upside: +531.58%
Unity Biotechnology
Mar 25, 2025
Maintains: Buy
Price Target: $6 → $4
Current: $1.14
Upside: +250.88%
Cognition Therapeutics
Mar 21, 2025
Maintains: Buy
Price Target: $11 → $8
Current: $0.42
Upside: +1,824.46%
REGENXBIO
Mar 20, 2025
Maintains: Buy
Price Target: $52
Current: $7.83
Upside: +564.11%
CervoMed
Mar 18, 2025
Maintains: Buy
Price Target: $14
Current: $9.48
Upside: +47.68%
Oculis Holding AG
Mar 13, 2025
Maintains: Buy
Price Target: $28
Current: $19.18
Upside: +45.99%
EyePoint Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $33
Current: $5.83
Upside: +466.04%
Ocugen
Mar 6, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $0.80
Upside: +775.55%
MeiraGTx Holdings
Feb 24, 2025
Maintains: Buy
Price Target: $36
Current: $7.33
Upside: +391.13%
Outlook Therapeutics
Feb 18, 2025
Maintains: Neutral
Price Target: $3
Current: $1.32
Upside: +127.27%
Dec 4, 2024
Maintains: Buy
Price Target: $64
Current: $8.20
Upside: +680.49%
Jul 18, 2024
Maintains: Buy
Price Target: $4 → $40
Current: $4.61
Upside: +767.68%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $2.78
Upside: +7,826.50%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.91
Upside: -